Colibactin (<i>pks</i>) carriage in <i>Escherichia coli</i> is associated with lineage restriction, reduced plasmid burden, and lower antimicrobial resistance.

Front Microbiol · 2026 · PMC13246691 · PMID 42273045

Europe PMC DOI

hedged sentence

0.0650

closest p · 1.3× alpha

0.0650

boldest claim

The sentences

did not reach statistical significanceP = 0.065so close (0.05 < p ≤ 0.1)

A phylogroup-controlled comparison within phylogroup B2 further showed that ARG counts co-occurring with plasmid replicon markers tended to be lower in pks -positive genomes ( Supplementary Figure S4 ), although this difference did not reach statistical significance ( P = 0.065). 3.6.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Colibactin (&lt;i&gt;pks&lt;/i&gt;) carriage in &lt;i&gt;Escherichia coli&lt;/i&gt; is associated with lineage restriction, reduced plasmid burden, and lower antimicrobial resistance.

The sentences

Colibactin (<i>pks</i>) carriage in <i>Escherichia coli</i> is associated with lineage restriction, reduced plasmid burden, and lower antimicrobial resistance.